Squamous cell skin papilloma

Summary

Squamous cell skin papilloma (MONDO:0004204) is a disease. A subtype of squamous papilloma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	squamous cell skin papilloma
Mondo ID	MONDO:0004204
DOID	DOID:7380
NCIT	C4462
SNOMED CT	254661000
UMLS	C0345983
MedGen	83397
Anatomy (UBERON)	UBERON:0000014
Is cancer (heuristic)	no

Also known as: Dyskeratotic papilloma of skin · Dyskeratotic papilloma of the skin · Dyskeratotic skin papilloma · hyperkeratotic papilloma of skin · hyperkeratotic papilloma of the skin · hyperkeratotic skin papilloma · parakeratotic papilloma of skin · parakeratotic papilloma of the skin · squamous cell papilloma of the skin · squamous cell skin papilloma · zone of skin squamous papilloma

Disease family

This is a subtype of squamous papilloma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › epithelial neoplasm › papillary epithelial neoplasm › papilloma › squamous papilloma › squamous cell skin papilloma

Related subtypes (7): larynx squamous papilloma, bladder squamous papilloma, vaginal squamous papilloma, vestibular papilloma, nasal vestibule squamous papilloma, cervix squamous papilloma, esophagus squamous cell papilloma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.